BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 32415259)

  • 1. Tertiary lymphoid structures in cancer - considerations for patient prognosis.
    Munoz-Erazo L; Rhodes JL; Marion VC; Kemp RA
    Cell Mol Immunol; 2020 Jun; 17(6):570-575. PubMed ID: 32415259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.
    Rodriguez AB; Engelhard VH
    Cancer Immunol Res; 2020 Nov; 8(11):1338-1345. PubMed ID: 33139300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
    N J; J T; Sl N; Gt B
    Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
    Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
    Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
    Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
    Front Immunol; 2018; 9():1952. PubMed ID: 30258435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary lymphoid structures in cancer and beyond.
    Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH
    Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.
    Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL
    Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609
    [No Abstract]   [Full Text] [Related]  

  • 12. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
    Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
    Front Immunol; 2021; 12():629519. PubMed ID: 33746966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.
    Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW
    Front Immunol; 2021; 12():675538. PubMed ID: 34054863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.
    Engelhard VH; Rodriguez AB; Mauldin IS; Woods AN; Peske JD; Slingluff CL
    J Immunol; 2018 Jan; 200(2):432-442. PubMed ID: 29311385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
    Rodriguez AB; Peske JD; Engelhard VH
    Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
    Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
    Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.